ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,777 | -39.8% | 10,365 | +15.4% | 0.00% | – |
| Q2 2023 | $192,215 | -68.2% | 8,982 | -39.9% | 0.00% | – |
| Q1 2023 | $603,930 | +20.9% | 14,934 | +39.1% | 0.00% | – |
| Q4 2022 | $499,531 | +12.8% | 10,738 | +25.8% | 0.00% | – |
| Q3 2022 | $443,000 | -4.3% | 8,534 | -13.0% | 0.00% | – |
| Q2 2022 | $463,000 | -40.6% | 9,807 | -10.4% | 0.00% | – |
| Q1 2022 | $779,000 | -75.3% | 10,947 | -74.0% | 0.00% | -100.0% |
| Q4 2021 | $3,150,000 | -16.5% | 42,139 | -36.6% | 0.00% | -50.0% |
| Q3 2021 | $3,774,000 | +34.8% | 66,427 | +4.4% | 0.00% | +100.0% |
| Q2 2021 | $2,800,000 | -31.1% | 63,611 | -22.7% | 0.00% | -50.0% |
| Q1 2021 | $4,061,000 | +38.6% | 82,337 | +18.3% | 0.00% | 0.0% |
| Q4 2020 | $2,931,000 | +448.9% | 69,625 | +497.3% | 0.00% | – |
| Q3 2020 | $534,000 | -92.5% | 11,657 | -91.8% | 0.00% | -100.0% |
| Q2 2020 | $7,133,000 | -47.1% | 142,055 | -45.8% | 0.01% | -58.3% |
| Q1 2020 | $13,478,000 | +70.7% | 262,072 | +105.0% | 0.01% | +140.0% |
| Q4 2019 | $7,898,000 | +1973.0% | 127,863 | +1906.6% | 0.01% | – |
| Q3 2019 | $381,000 | -45.3% | 6,372 | -23.2% | 0.00% | – |
| Q2 2019 | $697,000 | -87.8% | 8,298 | -86.2% | 0.00% | -100.0% |
| Q1 2019 | $5,723,000 | +5.2% | 59,938 | -22.0% | 0.00% | -25.0% |
| Q4 2018 | $5,440,000 | -49.4% | 76,836 | -38.9% | 0.00% | +33.3% |
| Q3 2018 | $10,753,000 | -4.2% | 125,831 | +29.9% | 0.00% | 0.0% |
| Q2 2018 | $11,223,000 | +69.2% | 96,853 | +18.1% | 0.00% | 0.0% |
| Q1 2018 | $6,633,000 | +201.6% | 82,006 | +118.7% | 0.00% | +200.0% |
| Q4 2017 | $2,199,000 | +156.0% | 37,499 | +103.8% | 0.00% | 0.0% |
| Q3 2017 | $859,000 | +27.1% | 18,397 | -2.2% | 0.00% | – |
| Q2 2017 | $676,000 | -57.5% | 18,807 | -63.6% | 0.00% | -100.0% |
| Q1 2017 | $1,589,000 | -26.4% | 51,640 | -19.9% | 0.00% | -50.0% |
| Q4 2016 | $2,158,000 | -52.1% | 64,444 | -61.9% | 0.00% | -33.3% |
| Q3 2016 | $4,501,000 | +62.7% | 169,234 | +34.8% | 0.00% | +50.0% |
| Q2 2016 | $2,766,000 | +42.7% | 125,579 | +90.2% | 0.00% | +100.0% |
| Q1 2016 | $1,938,000 | -56.1% | 66,038 | -50.6% | 0.00% | -66.7% |
| Q4 2015 | $4,411,000 | +588.1% | 133,648 | +652.2% | 0.00% | – |
| Q3 2015 | $641,000 | +0.3% | 17,768 | +25.0% | 0.00% | – |
| Q2 2015 | $639,000 | +129.0% | 14,214 | +55.1% | 0.00% | – |
| Q1 2015 | $279,000 | -93.0% | 9,162 | -88.4% | 0.00% | -100.0% |
| Q4 2014 | $4,003,000 | +31.2% | 78,734 | +2.0% | 0.00% | 0.0% |
| Q3 2014 | $3,052,000 | +149.1% | 77,167 | +171.2% | 0.00% | +100.0% |
| Q2 2014 | $1,225,000 | +63.1% | 28,456 | +51.4% | 0.00% | 0.0% |
| Q1 2014 | $751,000 | +928.8% | 18,795 | +598.4% | 0.00% | – |
| Q4 2013 | $73,000 | -81.6% | 2,691 | -84.5% | 0.00% | – |
| Q3 2013 | $396,000 | – | 17,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |